BIOMAT Database Logo BIOMAT Database Logo

Cytomegalo and herpes simplex virus infections in renal transplant recipients. 1985

P Wertheim, and K W Slaterus, and J L Geelen, and J van der Noordaa, and J M Wilmink

In a prospective study data were obtained from renal transplant recipients with respect to the incidence and source of infections by CMV and HSV. The incidence of infections with CMV and HSV appeared to be related to the immune suppression regimen used. Especially the high incidence of reinfection with CMV (88.0%) and HSV (81.0) at high prednisolone dosage compared to the lower incidence (CMV 54.5%, HSV 44.1%) at low prednisolone dosage was apparent. Even in very moderate immune suppressed patients infections occurred in at least 40% of them. These infections are known to be potentially harmful to the recipient or to the graft. CMV can be transmitted by the graft in both seronegative and seropositive recipients as demonstrated by restriction enzyme analysis. Therefore CMV related disease has to be considered in all recipients with grafts from seropositive donors. For CMV infection the diagnostic value of serology (CF test) appeared high, while for the diagnosis of HSV infection virus-isolation was of more value.

UI MeSH Term Description Entries
D007165 Immunosuppression Therapy Deliberate prevention or diminution of the host's immune response. It may be nonspecific as in the administration of immunosuppressive agents (drugs or radiation) or by lymphocyte depletion or may be specific as in desensitization or the simultaneous administration of antigen and immunosuppressive drugs. Antirejection Therapy,Immunosuppression,Immunosuppressive Therapy,Anti-Rejection Therapy,Therapy, Anti-Rejection,Therapy, Antirejection,Anti Rejection Therapy,Anti-Rejection Therapies,Antirejection Therapies,Immunosuppression Therapies,Immunosuppressions,Immunosuppressive Therapies,Therapies, Immunosuppression,Therapies, Immunosuppressive,Therapy, Immunosuppression,Therapy, Immunosuppressive
D011239 Prednisolone A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. Di-Adreson-F,Predate,Predonine,Di Adreson F,DiAdresonF
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D003428 Cross Infection Any infection which a patient contracts in a health-care institution. Hospital Infections,Nosocomial Infections,Health Care Associated Infection,Health Care Associated Infections,Healthcare Associated Infections,Infection, Cross,Infections, Hospital,Infections, Nosocomial,Cross Infections,Healthcare Associated Infection,Hospital Infection,Infection, Healthcare Associated,Infection, Hospital,Infection, Nosocomial,Infections, Cross,Infections, Healthcare Associated,Nosocomial Infection
D003586 Cytomegalovirus Infections Infection with CYTOMEGALOVIRUS, characterized by enlarged cells bearing intranuclear inclusions. Infection may be in almost any organ, but the salivary glands are the most common site in children, as are the lungs in adults. CMV Inclusion,CMV Inclusions,Congenital CMV Infection,Congenital Cytomegalovirus Infection,Cytomegalic Inclusion Disease,Cytomegalovirus Colitis,Cytomegalovirus Inclusion,Cytomegalovirus Inclusion Disease,Cytomegalovirus Inclusions,Inclusion Disease,Perinatal CMV Infection,Perinatal Cytomegalovirus Infection,Renal Tubular Cytomegalovirus Inclusion,Renal Tubular Cytomegalovirus Inclusions,Salivary Gland Virus Disease,Severe Cytomegalovirus Infection,Severe Cytomegalovirus Infections,Infections, Cytomegalovirus,CMV Infection, Congenital,CMV Infection, Perinatal,Colitis, Cytomegalovirus,Congenital CMV Infections,Congenital Cytomegalovirus Infections,Cytomegalic Inclusion Diseases,Cytomegalovirus Colitides,Cytomegalovirus Inclusion Diseases,Cytomegalovirus Infection,Cytomegalovirus Infection, Congenital,Cytomegalovirus Infection, Perinatal,Cytomegalovirus Infection, Severe,Cytomegalovirus Infections, Severe,Disease, Cytomegalic Inclusion,Disease, Cytomegalovirus Inclusion,Diseases, Cytomegalovirus Inclusion,Inclusion Disease, Cytomegalic,Inclusion Disease, Cytomegalovirus,Inclusion Diseases,Inclusion Diseases, Cytomegalovirus,Inclusion, CMV,Inclusion, Cytomegalovirus,Infection, Congenital CMV,Infection, Congenital Cytomegalovirus,Infection, Cytomegalovirus,Infection, Perinatal CMV,Infection, Perinatal Cytomegalovirus,Infection, Severe Cytomegalovirus,Perinatal CMV Infections,Perinatal Cytomegalovirus Infections
D003587 Cytomegalovirus A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS. Herpesvirus 5, Human,Human Herpesvirus 5,Salivary Gland Viruses,HHV 5,Herpesvirus 5 (beta), Human,Cytomegaloviruses,Salivary Gland Virus,Virus, Salivary Gland,Viruses, Salivary Gland
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006561 Herpes Simplex A group of acute infections caused by herpes simplex virus type 1 or type 2 that is characterized by the development of one or more small fluid-filled vesicles with a raised erythematous base on the skin or mucous membrane. It occurs as a primary infection or recurs due to a reactivation of a latent infection. (Dorland, 27th ed.) Herpes Simplex Virus Infection
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000914 Antibodies, Viral Immunoglobulins produced in response to VIRAL ANTIGENS. Viral Antibodies

Related Publications

P Wertheim, and K W Slaterus, and J L Geelen, and J van der Noordaa, and J M Wilmink
Occurrence of cytomegalo virus and herpes simplex virus infections in pregnancy.
January 2008, Indian journal of medical microbiology,
P Wertheim, and K W Slaterus, and J L Geelen, and J van der Noordaa, and J M Wilmink
Herpes simplex virus infections in solid organ transplant recipients.
December 2009, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons,
P Wertheim, and K W Slaterus, and J L Geelen, and J van der Noordaa, and J M Wilmink
α Herpes Virus Infections Among Renal Transplant Recipients.
September 2016, Seminars in nephrology,
P Wertheim, and K W Slaterus, and J L Geelen, and J van der Noordaa, and J M Wilmink
Herpes simplex keratitis in renal transplant recipients.
February 1981, Canadian Medical Association journal,
P Wertheim, and K W Slaterus, and J L Geelen, and J van der Noordaa, and J M Wilmink
Antiviral therapy of herpes virus infections in renal transplant recipients.
December 1988, Transplantation proceedings,
P Wertheim, and K W Slaterus, and J L Geelen, and J van der Noordaa, and J M Wilmink
The incidence of cytomegalo- and herpes simplex virus infections in renal allograft recipients treated with high dose recombinant leucocyte interferon: a controlled study.
January 1985, Scandinavian journal of urology and nephrology. Supplementum,
P Wertheim, and K W Slaterus, and J L Geelen, and J van der Noordaa, and J M Wilmink
Chronic intraoral herpes simplex infection in renal transplant recipients.
August 1986, Transplantation proceedings,
P Wertheim, and K W Slaterus, and J L Geelen, and J van der Noordaa, and J M Wilmink
Herpes simplex virus infection in heart-lung transplant recipients.
April 1990, Transplantation,
P Wertheim, and K W Slaterus, and J L Geelen, and J van der Noordaa, and J M Wilmink
A prospective study of cytomegalovirus and herpes simplex virus disease in renal transplant recipients.
November 1982, Journal of clinical pathology,
P Wertheim, and K W Slaterus, and J L Geelen, and J van der Noordaa, and J M Wilmink
Oral acyclovir therapy for mucocutaneous herpes simplex virus infections in immunocompromised marrow transplant recipients.
June 1985, Annals of internal medicine,
Copied contents to your clipboard!